![]() |
|
|
MS Cowlen and ML Toews
Department of Pharmacology, School of Medicine, University of Missouri- Columbia 65212.
Agonist-induced sequestration and internalization of alpha 1-adrenergic receptors were examined in DDT1 MF-2 cells. Pretreatment of cells with epinephrine or norepinephrine alone, but not with phorbol 12-myristate 13-acetate alone, resulted in a marked decrease in [3H]prazosin binding to intact cells at 4 degrees. These pretreatments resulted in little or no change in the fraction of alpha 1-adrenergic receptors exhibiting limited accessibility to the hydrophilic competing ligand epinephrine in short-time competition binding assays with intact cells and little or no change in the subcellular distribution of alpha 1-adrenergic receptors between the plasma membrane and light vesicle compartments as assessed by sucrose density gradient centrifugation assays. Pretreatment with a combination of agonist plus phorbol 12-myristate 13- acetate resulted in a greater decrease in [3H]prazosin binding at 4 degrees than was observed when cells were pretreated with agonist alone, induced the conversion of about half of cell surface alpha 1- adrenergic receptors to a form exhibiting limited accessibility to epinephrine in short-time assays, and induced a shift of about half of alpha 1-adrenergic receptors from the plasma membrane fraction to a light vesicle fraction on sucrose density gradients. A similar shift of alpha 1-adrenergic receptors was observed on sucrose density gradients after exposure to agonist plus either mezerein or beta-phorbol didecanoate, but not with agonist plus alpha-phorbol didecanoate, indicating involvement of protein kinase C. These results suggest that pretreatment with agonist alone induces the sequestration of alpha 1- adrenergic receptors into a compartment that is inaccessible to [3H]prazosin at 4 degrees but that is accessible to hydrophilic ligands at 37 degrees and remains associated with the plasma membrane. In contrast, alpha 1-adrenergic receptors are apparently internalized from the plasma membrane to a separate compartment, presumably an intracellular vesicle, when cells are pretreated simultaneously with a combination of agonist plus a protein kinase C activator.
This article has been cited by other articles:
![]() |
J. Wang, L. Wang, J. L. Anderson, N. A. Schulte, and M. L. Toews Regulatory Properties of alpha 1B-Adrenergic Receptors Defective in Coupling to Phosphoinositide Hydrolysis J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 134 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L. Wang, J. Zheng, J. L. Anderson, and M. L. Toews Identification of Distinct Carboxyl-Terminal Domains Mediating Internalization and Down-Regulation of the Hamster alpha 1B- Adrenergic Receptor Mol. Pharmacol., April 1, 2000; 57(4): 687 - 694. [Abstract] [Full Text] |
||||
![]() |
F. R. M. Stassen, R. G. H. T. Maas, P. M. H. Schiffers, G. M. J. Janssen, and J. G. R. De Mey A Positive and Reversible Relationship Between Adrenergic Nerves and Alpha-1A Adrenoceptors in Rat Arteries J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 399 - 405. [Abstract] [Full Text] |
||||
![]() |
J. Wang, J. Zheng, J. L. Anderson, and M. L. Toews A Mutation in the Hamster alpha 1B-Adrenergic Receptor that Differentiates Two Steps in the Pathway of Receptor Internalization Mol. Pharmacol., August 1, 1997; 52(2): 306 - 313. [Abstract] [Full Text] |
||||